From DCAT Value Chain Insights (VCI)
AstraZeneca has named Pam P. Cheng as executive vice president, operations and IT. Pam will succeed David Smith, who is retiring after nearly ten years with AstraZeneca. Pam will be responsible for manufacturing operations and supply chain, procurement, and information technology globally. In the role, she will oversee continued progress in driving efficiency and delivering excellence in these areas.Pam will report to AstraZeneca CEO Pascal Soriot and will be a member of AstraZeneca’s Senior Executive Team.
Pam joins AstraZeneca from Merck/MSD, where she gained extensive experience in pharmaceuticals manufacturing and supply chain management. She played a lead role in restructuring and upgrading the company’s manufacturing technology and engineering capabilities as director of global planning and capacity management, and as head of global supply chain management and logistics led the transformation of the company’s supply chains across its global network. Most recently, Pam was chief operating officer and then president of MSD China. Prior to joining Merck, Pam held process engineering roles at Union Carbide and GAF Chemicals.
Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT).
Learn more and sign up to receive a complimentary subscription